Home
Ferrer

Ferrer Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domainferrer.com

Year Founded1959

Employees1001 - 5000

Annual Revenue$100M - $200M

Ferrer

Ferrer (including company regionals)

ferrer.com

See more website traffic and engagement information

Ferrer Revenue up to August 2026 is 100M - 200M

revenue generated by Ferrer top domains

Ferrer top domains revenue over 3 years

Revenue for Ferrer top domains

ferrer.com100M - 200M

See more with Sales Intelligence

Total visits to Ferrer's top domains

Understand Ferrer market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ferrer.com27.2K

See more with Sales Intelligence

Avg. visit duration in Ferrer's top domains

Analyze Ferrer engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ferrer.com00:00:27

See more with Sales Intelligence

Avg. pageviews on Ferrer's top domains

See how Ferrer keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ferrer.com1.58

See more with Sales Intelligence

Ferrer top competitors by domain

Top similar sites in August 2026, ranked by their affinity

boehringer-ingelheim.cnCompany NameBoehringer IngelheimEmployees> 10001HQGermany, ingelheim am rheinAnnual revenue> $1BTotal visits7.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Ferrer

These are the website technologies, by industry, used by Ferrer top domains

Payment & Currencies (22)

PayPal

Advertising (9)

DoubleClick

Social (6)

Instagram

Content Management System (5)

WordPress

More Technologies

10

See all

News & Signals from Ferrer

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFerrer sold assets to Cooper on Jun 26th '26.* In the corporate arena, Ferrer agreed to sell Gelocatil and the rest of its over-the-counter drug portfolio to French company Cooper, an operation that will allow the Catalan company to focus on its priority therapeutic areas.

NewsFerrer partnered with Prilenia on Apr 28th '25.Evy Reviers, Chairwoman of the European Organisation of Professionals and People with ALS (EUpALS) comments: "EUpALS welcomes that Ferrer and Prilenia joined forces to initiate the PREVAiLS Phase 3 Study as it represents continued progress in rigorous clinical research in ALS.

NewsFerrer recognized as World's Most Ethical Companies(R) on Jan 1st '26.Ferrer included in the ranking of the World's Most Ethical Companies(R) in 2026.